Of the fourteen genes for which we found suitable germline genetic instruments, two—RHOD and CDC42—showed evidence of a link with breast cancer risk with the evidence being stronger for RHOD. The expression level of RHOD and CDC42 demonstrated positive and inverse effects on overall breast cancer, respectively. This evidence concerns the gene CDC42 and breast cancer.